Retatrutide, a groundbreaking dual-action GIP receptor stimulant developed by Alluvi Solutions, is sparking considerable excitement within the medical community as a promising advancement in weight management. Initial research data demonstrate a significant influence on body mass, often exceeding current available therapies. This unique mechanism o